Premium
First and second trimester maternal serum markers in pregnancies with a vanishing twin
Author(s) -
Huang Tianhua,
Boucher Karen,
Aul Ritu,
Rashid Shamim,
Meschino Wendy S.
Publication year - 2015
Publication title -
prenatal diagnosis
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.956
H-Index - 97
eISSN - 1097-0223
pISSN - 0197-3851
DOI - 10.1002/pd.4492
Subject(s) - medicine , twin pregnancy , obstetrics , pregnancy , gestational age , singleton , fetus , gestation , second trimester , gynecology , retrospective cohort study , pregnancy associated plasma protein a , first trimester , biology , genetics
Objective The aim of this study was to assess the concentration of the first and second trimester maternal serum markers in pregnancies with a vanishing twin. Methods This is a retrospective case–control study of pregnancies screened for Down syndrome in one Ontario center. Singleton pregnancies with ultrasound evidence of a vanishing twin were identified, and each was matched with five normal singleton controls for ethnicity, maternal age, gestational age, and blood sampling date. The median MoM of the first and second trimester serum markers was compared between cases and controls. The differences were assessed using the Mann–Whitney U ‐test. Results The study included 174 pregnancies that had a vanishing twin. Compared with control pregnancies, pregnancy associated plasma protein A increased by 21% ( p = 0.0026), alpha‐fetoprotein (AFP) increased by 10% ( p < 0.0001), and dimeric inhibin A (DIA) increased by 13% ( p = 0.0470) in pregnancies with a vanishing twin. Unconjugated oestriol and total human chorionic gonadotrophin were not significantly changed in these pregnancies. Conclusions Pregnancy associated plasma protein A is not an adequate marker for pregnancies with a vanishing twin. The impact of elevated AFP on risk estimation is offset by that of DIA to certain extent. Further studies are needed to establish an adequate adjustment method for AFP and DIA to improve the accuracy of screening results for these pregnancies. © 2014 John Wiley & Sons, Ltd.